Alfred M. Cohen, MD, FACS, FASCRS, Joins as Director, Cancer Biosignature Programs
Alfred M. Cohen, MD, FACS, FASCRS, has joined Critical Path Institute (C-Path) as Director of its Cancer Biosignature Programs.
Related Posts
-
C-Path welcomes Kay Holcombe to its Board of Directors -
C-Path CEO Dr. Martha Brumfield Interviewed for RAPS Regulatory Exchange Member Spotlight -
Critical Path Institute Announces Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors
-
El Tour de Tucson, 2015 -
AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader